Editors’ Picks, February 2025: Improving CAR T, Studying Breast Cancer Risk, and More
This month, the editors of AACR's journals show their love for studies about CAR T-cell efficacy, breast cancer risk, and more.
Progress Against Cancer
This month, the editors of AACR's journals show their love for studies about CAR T-cell efficacy, breast cancer risk, and more.
Researchers are examining ways to make treatments more targeted to each type of biliary tract cancer or to each patient.
As winter marches on, let’s dive into the cool articles highlighted this month by the editors of the AACR journals. Grab a blanket and keep reading to learn how nicotine levels in e-cigarettes impact...
A therapeutic HPV vaccine showed remarkable benefits for patients with high-grade cervical precancers.
At the 2024 San Antonio Breast Cancer Symposium, researchers discussed clinical trials for vaccines and other ways to prevent breast cancer.
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
Our annual Experts Forecast offers insights from AACR President-Elect Lillian Siu, John E. Dick, Regina Barzilay, Vinod Balachandran, and Scarlett Lin Gomez.
Androgen deprivation therapy, a common prostate cancer treatment, may increase cognitive difficulties.
Shorter courses of more intense radiation therapy mean fewer visits and less cost for patients. Studies show abbreviated treatments are just as effective as longer courses.
With targeted therapy options available for a growing number of cancer types, biomarker testing is making a difference for more people with solid cancers.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More